The restorative effect of ascorbic acid on liver injury inducedby asymmetric dimethylarginine

Insufficient recovery in biochemical/histopathological parameters when AA was given make us consider that different factors other than prooxidant factors are effective in the formation of liver injury.

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:We aimed to determine whether increased levels of asymmetric dimethylarginine (ADMA) directly cause hepatic deterioration and whether it is decreased by ascorbic acid (AA) as an antioxidant.

📊

Temel Bulgular & Veri:The study included three groups: Control (n = 10), ADMA (n = 10), and ADMA + AA (n = 10).

💡

Sonuç & Katkı:Insufficient recovery in biochemical/histopathological parameters when AA was given make us consider that different factors other than prooxidant factors are effective in the formation of liver injury.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Abstract

We aimed to determine whether increased levels of asymmetric dimethylarginine (ADMA) directly cause hepatic deterioration and whether it is decreased by ascorbic acid (AA) as an antioxidant. The study included three groups: Control (n = 10), ADMA (n = 10), and ADMA + AA (n = 10). ADMA was administered at 2 mg kg-1 day-1 and AA was given at 50 mg kg-1 day-1 for 10 days. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase, and alkaline phosphatase activities were analyzed. Histomorphological evaluation of the liver was performed based on the Ishak scoring system. When compared with the control, ALT and ALP levels of the ADMA group were significantly higher (P = 0.006 and P = 0.041, respectively). When compared with the control, interface hepatitis, confluent necrosis, focal necrosis, histological activity index, severity of hepatitis, and portal inflammation were significantly higher in the group administered ADMA. The mentioned biochemical/histopathological parameters were lower in the ADMA + AA group when compared with the ADMA group even if no significant difference was encountered (P > 0.05). The results indicate that ADMA is a factor in the formation of liver injury. Insufficient recovery in biochemical/histopathological parameters when AA was given make us consider that different factors other than prooxidant factors are effective in the formation of liver injury.

🔖

Bu Makaleye Atıf Yap

TERZİ, Y., ALAÇAM, H., GÖREN, İ., ŞALIŞ, O., İLKAYA, F., KELEŞ, M. E., OKUYUCU, A., GÜVENLİ, A., ALICI, Ö. (2022). The restorative effect of ascorbic acid on liver injury inducedby asymmetric dimethylarginine. Turkish Journal of Biology, Cilt: 40 - Sayı: 2, 452–461. https://ajindex.com/articles/600380

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

Alaçam H, Avcı B, Şalış O, Dilek A, Kozan A, Mertoğlu C, Şahin M, Okuyucu A (2013). Does ADMA affect the oxidant/antioxidant balance in rats? Turk J Med Sci 43: 405–410.
Alacam H, Dikmen ZG, Yaman H, Cakir E, Deren O, Akgul EO, Aydin I, Kurt YG, Keskin U, Akalin S et al. (2011). The role of asymmetric dimethyl arginine and oxidant/antioxidant system in preeclampsia. Fetal Pediatr Pathol 30: 387–393.
Anderstam B, Katzarski K, Bergstrom J (1997).
Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol 8: 1437–1442.
Avci B, Alacam H, Dilek A, Kozan A (2015). Effects of asymmetric dimethylarginine on inflammatory cytokines (TNF-alpha, IL-6 and IL-10) in rats. Toxicol Ind Health 31: 268–273.
Bal F, Bekpinar S, Unlucerci Y, Kusku-Kiraz Z, Onder S, Uysal M, Gurdol F (2014). Antidiabetic drug metformin is effective on the metabolism of asymmetric dimethylarginine in experimental liver injury. Diabetes Res Clin Pract 106: 295– 302. Beltowski J, Kedra A (2006). Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy. Pharmacol Rep 58: 159–178.
Bode-Boger SM, Scalera F, Ignarro LJ (2007). The L-arginine paradox: importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther 114: 295–306.
Cerwinka WH, Cooper D, Krieglstein CF, Feelisch M, Granger DN (2002). Nitric oxide modulates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol 282: H1111–1117. Closs EI, Graf P, Habermeier A, Cunningham JM, Forstermann U (1997). Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: three related carriers with distinct transport properties. Biochemistry 36: 6462–6468.
Donpunha W, Kukongviriyapan U, Sompamit K, Pakdeechote P, Kukongviriyapan V, Pannangpetch P (2011). Protective effect of ascorbic acid on cadmium-induced hypertension and vascular dysfunction in mice. Biometals 24: 105–115.
Fan C, Zwacka RM, Engelhardt JF (1999). Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med (Berl) 77: 577–592.
Ferrigno A, Di Pasqua LG, Berardo C, Richelmi P, Vairetti M (2015). Liver plays a central role in asymmetric dimethylarginine-mediated organ injury. World J Gastroenterol 21: 5131–5137.
Ferrigno A, Rizzo V, Bianchi A, Di Pasqua LG, Berardo C, Richelmi P, Vairetti M (2014). Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. Biomed Res Int 2014: 627